Trial: azithromycin versus erythromycin before endoscopy in upper gastrointestinal bleeding

Phase 1

• Conditions: pper gastrointestinal haemorrhage; MedDRA version: 19.1Level: PTClassification code 10046274Term: Upper gastrointestinal haemorrhageSystem Organ Class: 10017947 - Gastrointestinal disorders; Therapeutic area: Diseases [C] - Digestive System Diseases [C06]

• Registration Number: EUCTR2016-003339-39-ES
• Lead Sponsor: JOSÉ MARÍA PALAZÓN AZORÍ

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-04-07
• Last Update Posted: 22 May 2017

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients older than 18 years with upper gastrointestinal bleeding defined as hematemesis, melena or coffee-ground hematemesist. Informed consent provided.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 120
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 120

Exclusion Criteria

Allergy, interactions or contraindications to macrolides, previous administration of prokinetic agents in this episode, perforation or previous gastric surgery, history of cardiac arrhytnmias, acute myocardial infarction or cerebrovascular disease in the last 3 weeks, pregnancy or lactation.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified